Novel subgroups of type 2 diabetes based on multi-Omics profiling: an IMI-RHAPSODY Study

Shiying Li, Iulian Dragan, Chun Ho Fung, Dmitry Kuznetsov, Michael K. Hansen, Joline W.J. Beulens, Leen M. ’t Hart, Roderick C. Slieker, Louise A. Donnelly, Mathias J. Gerl, Christian Klose, Florence Mehl, Kai Simons, Petra JM Elders, Ewan R. Pearson, Guy A. Rutter, Mark Ibberson
doi: https://doi.org/10.1101/2022.09.03.22279563

Article usage

Article usage: September 2022 to June 2025

AbstractFullPdf
Sep 20225691385
Oct 2022144217
Nov 202295714
Dec 202254115
Jan 202354419
Feb 202352220
Mar 202359314
Apr 202334115
May 20232828
Jun 20231446
Jul 202315116
Aug 2023531224
Sep 20232447
Oct 20232129
Nov 20232236
Dec 20232013
Jan 202420110
Feb 20241612
Mar 20243307
Apr 202414210
May 20241944
Jun 20243825
Jul 202418010
Aug 20241934
Sep 20243647
Oct 20242754
Nov 20241718
Dec 20242859
Jan 20251535
Feb 2025291211
Mar 2025241922
Apr 202528420
May 202524612
Jun 202519811
Back to top
Posted September 04, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Novel subgroups of type 2 diabetes based on multi-Omics profiling: an IMI-RHAPSODY Study
Shiying Li, Iulian Dragan, Chun Ho Fung, Dmitry Kuznetsov, Michael K. Hansen, Joline W.J. Beulens, Leen M. ’t Hart, Roderick C. Slieker, Louise A. Donnelly, Mathias J. Gerl, Christian Klose, Florence Mehl, Kai Simons, Petra JM Elders, Ewan R. Pearson, Guy A. Rutter, Mark Ibberson
medRxiv 2022.09.03.22279563; doi: https://doi.org/10.1101/2022.09.03.22279563
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area